554 related articles for article (PubMed ID: 19167016)
1. Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study.
Walters AS; Ondo WG; Zhu W; Le W
J Neurol Sci; 2009 Apr; 279(1-2):62-5. PubMed ID: 19167016
[TBL] [Abstract][Full Text] [Related]
2. Brain enkephalin receptors in Parkinson's disease.
Rinne UK; Rinne JK; Rinne JO; Laakso K; Tenovuo O; Lönnberg P; Koskinen V
J Neural Transm Suppl; 1983; 19():163-71. PubMed ID: 6321647
[TBL] [Abstract][Full Text] [Related]
3. Is ferroportin-hepcidin signaling altered in restless legs syndrome?
Clardy SL; Wang X; Boyer PJ; Earley CJ; Allen RP; Connor JR
J Neurol Sci; 2006 Sep; 247(2):173-9. PubMed ID: 16759669
[TBL] [Abstract][Full Text] [Related]
4. [A study of opioid peptides in synovial fluid and synovial tissue in patients with rheumatoid arthritis].
Suzuki N; Yoshino S; Nakamura H
Arerugi; 1992 May; 41(5):615-20. PubMed ID: 1520070
[TBL] [Abstract][Full Text] [Related]
5. Arginine vasopressin induces periaqueductal gray release of enkephalin and endorphin relating to pain modulation in the rat.
Yang J; Yang Y; Xu HT; Chen JM; Liu WY; Lin BC
Regul Pept; 2007 Jul; 142(1-2):29-36. PubMed ID: 17341433
[TBL] [Abstract][Full Text] [Related]
6. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
7. Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson's disease.
Sun YM; Hoang T; Neubauer JA; Walters AS
J Neurol Sci; 2011 May; 304(1-2):93-101. PubMed ID: 21376342
[TBL] [Abstract][Full Text] [Related]
8. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
Yurdaydin C; Li Y; Ha JH; Jones EA; Rothman R; Basile AS
J Pharmacol Exp Ther; 1995 Apr; 273(1):185-92. PubMed ID: 7714765
[TBL] [Abstract][Full Text] [Related]
9. MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.
Earley CJ; B Barker P; Horská A; Allen RP
Sleep Med; 2006 Aug; 7(5):458-61. PubMed ID: 16740411
[TBL] [Abstract][Full Text] [Related]
10. Plasma met-enkephalin, beta-endorphin and leu-enkephalin levels in human hepatic encephalopathy.
Kamel L; Saleh A; Morsy A; Ghali A; El Khayat H
East Mediterr Health J; 2007; 13(2):257-65. PubMed ID: 17684846
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin K generates enkephalin from beta-endorphin: a new mechanism with possible relevance for schizophrenia.
Lendeckel U; Kähne T; Ten Have S; Bukowska A; Wolke C; Bogerts B; Keilhoff G; Bernstein HG
Neurochem Int; 2009 Jun; 54(7):410-7. PubMed ID: 19428782
[TBL] [Abstract][Full Text] [Related]
12. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome.
Wang X; Wiesinger J; Beard J; Felt B; Menzies S; Earley C; Allen R; Connor J
J Neurol Sci; 2004 May; 220(1-2):59-66. PubMed ID: 15140607
[TBL] [Abstract][Full Text] [Related]
13. Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome.
Walters AS; Li Y; Koo BB; Ondo WG; Weinstock LB; Champion D; Afrin LB; Karroum EG; Bagai K; Spruyt K
Brain; 2024 Jan; 147(1):26-38. PubMed ID: 37633259
[TBL] [Abstract][Full Text] [Related]
14. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.
Connor JR; Wang XS; Allen RP; Beard JL; Wiesinger JA; Felt BT; Earley CJ
Brain; 2009 Sep; 132(Pt 9):2403-12. PubMed ID: 19467991
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease and RLS: the dopaminergic bridge.
Rye DB
Sleep Med; 2004 May; 5(3):317-28. PubMed ID: 15165542
[TBL] [Abstract][Full Text] [Related]
16. Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome.
Timmers K; Voyles NR; Zalenski C; Wilkins S; Recant L
Diabetes; 1986 Oct; 35(10):1143-51. PubMed ID: 2944783
[TBL] [Abstract][Full Text] [Related]
17. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
Brown SL; Van Epps DE
J Immunol; 1985 May; 134(5):3384-90. PubMed ID: 3156934
[TBL] [Abstract][Full Text] [Related]
18. [Opioid peptides in cerebrospinal fluids of epileptic patients].
Xie X
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Feb; 24(1):15-7, 60-1. PubMed ID: 1907903
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactive beta-endorphin and met- and leu-enkephalin contents in pancreas and pituitary of corpulent (cp/cp) rats.
Timmers K; Voyles NR; Wilkins S; Michaelis OE; Bhathena SJ; Recant L
Int J Obes; 1989; 13(3):337-45. PubMed ID: 2527831
[TBL] [Abstract][Full Text] [Related]
20. Evidence for enkephalin- and endorphin-immunoreactive cells in the anterior pituitary of the axolotl Ambystoma mexicanum.
Leon-Olea M; Sanchez-Alvarez M; Piña AL; Bayon A
J Comp Neurol; 1991 Mar; 305(3):412-20. PubMed ID: 1674748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
